| Prev Close | 3.80 |
| Day Low/High | 0.00 / 0.00 |
| 52 Wk Low/High | 2.55 / 26.95 |
| Avg Volume | 1.24M |
| Exchange | NASDAQ |
| Shares Outstanding | 52.50M |
| Market Cap | 202.14M |
| EPS | -2.30 |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Latest News
Cempra To Report First Quarter 2017 Financial Results
—Management to host webcast and conference call on Friday, April 28, 2017 at 8:45 a.m. ET—
Biotech Premarket Movers: Cempra, Tesaro, Editas
Cempra, Tesaro and Editas Medicine were among the biotech stock movers in premarket trading on Tuesday.
Cempra Withdraws Solithromycin Marketing Authorization Application In Europe
—Company plans to resubmit MAA with additional data, in alignment with FDA strategy—
Biotech Premarket Movers: Cempra, Blueprint Medicines, Aralez
Cempra, Blueprint Medicines and  Aralez Pharmaceuticals were among the biotech stock movers in premarket trading on Monday.
Cempra To Present At 29th Annual ROTH Conference
—Presentation time at Cowen and Company 37th Annual Health Care Conference on Monday, March 6 changed to 2:40 p.m. ET—
Biotech Premarket Movers: Cempra, Novavax, Ionis
Cempra, Novavax and Ionis Pharmaceuticals were among the biotech stock movers in premarket trading on Tuesday.
Biotech Premarket Movers: BioCryst, Sangamo, Cempra
BioCryst Pharmaceuticals, Sangamo Therapeutics and Cempra were among the biotech stock movers in premarket trading on Monday.
4 Biotech Stocks on the Move
These four biotech stocks have been moving on some interesting news and clinical results.
Biotech Movers: Cempra Flys High On Phase Three Results
Other movers include Incyte, Achillion and Inovio.
Cempra To Report Fourth Quarter And Full Year 2016 Financial Results
Management to host webcast and conference call on Tuesday, February 28, 2017 at 8:45 a.m. EST
Acorda, Amgen and Regeneron Lead Premarket Biotech Movers
Acorda was soaring ahead of the market open, thanks to positive late-stage clinical trial results for levodopa.
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Cempra, Inc. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of January 3, 2017
The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Cempra, Inc.
GPM Reminds Investors Of The January 3 Deadline In The Class Action Lawsuit Against Cempra, Inc.
Glancy Prongay & Murray LLP ("GPM") reminds investors of the January 3, 2017Â deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Cempra, Inc.
Wall Street Falls Again as Financial Stocks Lead the Decline
Stocks slumped for the second consecutive day as markets adjust to mixed economic data and the financial sector led the decline.
Wall Street Slumps As Financial Stocks Lead the Decline
Stocks are volatile at midday Thursday and are turning mostly negative as markets adjust to mixed economic data and as the financial sector slumps.
Midday Report: Volatile Stocks Turn Negative; Cempra Plummets, Sears Soars
Stocks were volatile Thursday as markets adjust to mixed economic data. Sears shares are seeing a boost while Cempra's stock plummets.
Stocks Volatile After Trade Deficit Data; Oil Inventories Rise
Stocks were mixed Thursday morning as markets adjusted to losses on Wednesday and investors received mixed economic data.
Cempra Receives Complete Response Letter From FDA For Solithromycin NDAs
Management to host webcast and conference call today at 9:00 a.m. ET
CEMP SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Shareholders Of Commencement Of A Class Action Involving Cempra, Inc. And A Lead Plaintiff Deadline Of January 3, 2017
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Middle District of North Carolina on behalf of investors who purchased Cempra, Inc.
